Actinium Pharmaceuticals, Inc.·4

Jul 16, 5:02 PM ET

SETH SANDESH 4

4 · Actinium Pharmaceuticals, Inc. · Filed Jul 16, 2019

Insider Transaction Report

Form 4
Period: 2019-07-12
SETH SANDESH
Director
Transactions
  • Award

    Options to purchase common stock

    2019-07-12$0.23/sh+1,500,000$348,0001,500,000 total
    Exercise: $0.23From: 2019-07-12Exp: 2029-07-12Common Stock (1,500,000 underlying)
Footnotes (1)
  • [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant.

Documents

1 file
  • 4
    ownership.xmlPrimary